ADCs remain à la mode in the oncology sector, with Merck & Co (MSD) tying up another deal to advance its pipeline in the ...

Experts have finally uncovered a 'big bang' moment which determines how bowel cancer will grow, in landmark research ...

Experts have finally uncovered a 'big bang' moment which determines how bowel cancer will grow, in landmark research ...

Experimental, drug-free, MRI-guided cancer treatment may one day offer a way of targeting and destroying pancreatic tumors ...

By combining LED technology and nanomaterials, researchers have created a therapy that eliminates cancer cells using ...

The firm is now offering combined ex vivo drug sensitivity and genomic testing to cancer patients outside the clinical trial setting.

A revolutionary non-invasive tumor treatment is showing remarkable results in Hong Kong, although it is not yet widely ...

To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...

Sir2, an enzyme belonging to sirtuins, has been shown to be involved in the deacetylation of proteins. Researchers from the ...

Coherence Neuro co-founders Elise Jenkins and Ben Woodington have announced the company's $10 million seed round on social media.

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...